AG003R7E

103577-45-3 | 1H-​Benzimidazole, 2-​[[[3-​methyl-​4-​(2,​2,​2-​trifluoroethoxy)​-​2-​pyridinyl]​methyl]​sulfinyl]​-

AG003R7E

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	103577-45-3
Catalog Number	AG003R7E(AGN-PC-0OSH5L)
Chemical Name	1H-​Benzimidazole, 2-​[[[3-​methyl-​4-​(2,​2,​2-​trifluoroethoxy)​-​2-​pyridinyl]​methyl]​sulfinyl]​-
IUPAC Name	2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
InChI	InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)
InChI Key	MJIHNNLFOKEZEW-UHFFFAOYSA-N
MDL Number	MFCD00866873
Molecular Formula	C16H14F3N3O2S
Molecular Weight	369.3615
SMILES	S(=O)(Cc1c(C)c(OCC(F)(F)F)ccn1)c1nc2c([nH]1)cccc2
Synonyms	2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole, AG 1749, AG-1749, AG1749, Agopton, Bamalite, Lansol, lansoprazol, lansoprazole, Lansoprazole Sodium, Lansoprazoles, Lanzor, Monolitum, Ogast, Ogastro, Opiren, Prevacid, Prezal, Pro Ulco, Promeco, Sodium, Lansoprazole, Takepron, Ulpax, Zoton, lansoprazole, 103577-45-3, Prevacid, Bamalite, Monolitum, Lansoprazol, Agopton, Limpidex, Ogastro, Lanzor, Opiren, Prevacid SoluTab, Lanzopral, Takepron, Zoton, Lansoprazolum, Lanproton, Lansopep, Lasoprol, Mesactol, Aprazol, Blason, Ketian, Lancid, Lanston, Prezal, Ulpax, Lanz, Pro Ulco, AG-1749, Compraz, Ilsatec, Prosogan, Suprecid, Dakar, Promp, Zoprol, Prevacid Iv, Ogast, Lanzol-30, AG 1749, Lansoprazol [INN-Spanish], Lansoprazolum [INN-Latin], Lansox, Lanzo, A-65006, Prevacid NapraPAC, Prevacid 24HR, Lansoprazole [USAN:BAN:INN], CHEBI:6375, HSDB 7204, A 65006, TAK-390MR, BRN 4333393, 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole, MLS000069705, C16H14F3N3O2S, MFCD00866873, 2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole, 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole, NCGC00015615-02, CPD000058469, SMR000058469, CAS-103577-45-3, DSSTox_CID_3200, MLS-0003247.0001, 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole, 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole, 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole, DSSTox_RID_76922, DSSTox_GSID_23200, Prevacid I.V., TAK 390MR, Lansophed, Lanzol, Lanzul, PrevOnco, Biuret Gr, Prevacid I.V, 1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-, 2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole, 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole, 2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole, 2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole, Prevacid (TN), 2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole;2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole, Biuret Reagent Solution, SR-01000000169, Lanfast, Lapraz, Biuret reagent, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole, 2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl}-1H-benzimidazole, ABT-006, Lansoprazole,(S), Lansoprazole [USAN:USP:INN:BAN], LANSAPRAZOLE, CG-4801, PubChem16834, Spectrum_001580, Prevacid Delayed Release, Opera_ID_1676, Prestwick0_001072, Prestwick1_001072, Prestwick2_001072, Prestwick3_001072, Spectrum2_000444, Spectrum3_000295, Spectrum4_000856, Spectrum5_001521, Lopac-L-8533, CHEMBL480, L 8533, AC1L1GX8, cid_3883, Lopac0_000709, SCHEMBL22365, BSPBio_001084, BSPBio_001830, KBioGR_001491, KBioSS_002060, MLS000759405, MLS001074170, MLS001424235, BIDD:GT0006, DivK1c_000920, SPECTRUM1503926, SPBio_000488, SPBio_002992, BPBio1_001194, GTPL7208, DTXSID4023200, BDBM47032, CTK8F0500, HMS502N22, KBio1_000920, KBio2_002060, KBio2_004628, KBio2_007196, KBio3_001330, KS-00000VHO, Lansoprazole (JP17/USP/INN), MJIHNNLFOKEZEW-UHFFFAOYSA-N, NINDS_000920, HMS1571G06, HMS1922M04, HMS2052F05, HMS2093M07, HMS2098G06, HMS2234B10, HMS3262M19, HMS3264E12, HMS3269D15, HMS3371E21, HMS3394F05, HMS3654J17, HMS3677J05, HMS3715G06, Pharmakon1600-01503926, Pharmakon1600-01504282, ACT03358, BCP22331, EBD14854, T 168390 pound notTAK 390, Tox21_110184, Tox21_301023, Tox21_500709, BBL029072, BDBM50070208, BG0232, CCG-39952, CL0035, GP5308, NSC758638, NSC758710, s1354, STK621169, AKOS005554811, Tox21_110184_1, AC-1233, API0005388, CS-1847, DB00448, KS-1075, Lansoprazole, >=98% (TLC), powder, LP00709, MCULE-8446262134, NC00411, NSC-758638, NSC-758710, SB19127, 2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole, IDI1_000920, NCGC00015615-01, NCGC00015615-03, NCGC00015615-04, NCGC00015615-05, NCGC00015615-06, NCGC00015615-07, NCGC00015615-08, NCGC00015615-09, NCGC00015615-10, NCGC00015615-11, NCGC00015615-12, NCGC00015615-14, NCGC00015615-15, NCGC00023826-03, NCGC00023826-04, NCGC00023826-05, NCGC00023826-06, NCGC00023826-07, NCGC00254925-01, NCGC00261394-01, AK308448, AN-15125, BC208317, CC-29843, HY-13662, LS-33080, SAM001246544, SC-15158, SBI-0050687.P003, AB0005100, AB2000063, Prevacid;Prevacid NapraPAC;Prevacid SoluTab, RT-013461, TL8000155, AB00052388, EU-0100709, FT-0082011, FT-0610894, L0233, ST51015040, SW197226-4, D00355, AB00052388-17, AB00052388_18, AB00052388_19, 577L453, A800764, C-21097, I06-0018, J-007154, SR-01000000169-2, SR-01000000169-6, SR-01000000169-9, BRD-A49172652-001-05-7, BRD-A49172652-001-13-1, F2173-0222, Lansoprazole, British Pharmacopoeia (BP) Reference Standard, Lansoprazole, European Pharmacopoeia (EP) Reference Standard, Lansoprazole, United States Pharmacopeia (USP) Reference Standard, (+)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole, 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfinyl)benzimidazol e, 2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole, 2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole, 2-[(S)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole, 2-[[ [3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl]methyl]-sulfinyl]1H-benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulfinyl]benzimidazole, 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylsulfinyl]benzimidazole, 2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole, 2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzimidazole, 2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-benzimidazole, 2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl]-benzimidazole, 2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl]-1H-benzimidazole, 2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl]-1H-benzimidazole, Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard, 1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-, Amarin, dexlansoprazole, (R)-Lansoprazole, lanzoprazole, Prevpac, Promeco, dexilant, lansor, Lansoprazoles, Lanzole, Biuret, Lansol, Alter, Lansoprazole?, lansoprazole sulphone, dexlansoprazole MR, (S)-Lansoprazole, Lansoprazole sodium, Takepron (TN), Agopton (TN), (+-)-Lansoprazol, Lansox (TN), Sodium, Lansoprazole, LINAMARIN, (+-)-Lansoprazole, Ogast (TN), TAP Brand of Lansoprazole, UNII-0K5C5T2QPG, Abbot Brand of Lansoprazole, Vinas Brand of Lansoprazole, Wyeth Brand of Lansoprazole, TAK390MR, Salvar Brand of Lansoprazole, Takeda Brand of Lansoprazole, Hoechst Brand of Lansoprazole, Hormona Brand of Lansoprazole, Lederle Brand of Lansoprazole, Promeco Brand of Lansoprazole, D0M4HV, Almirall Brand of Lansoprazole, Tecnobio Brand of Lansoprazole, 0K5C5T2QPG, R-(+)-LANSOPRAZOLE, Lansoprazole, 98% 500mg, Lansoprazole (JAN/USP/INN), Lansoprazole [USAN:INN:BAN], CID3883, AG1749, ACN-053790, CS-O-10277, 138530-94-6, C16-H14-F3-N3-O2-S, A1229, B1725, C058687, D064747, lansoprazole, 98%, a proton pump inhibitor - 1G 1g, Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole, 138530-95-7, 1H-Bencimidazol, 2-[[[3-metil-4-(2,2,2-trifluoroethoxi)-2-piridinilo] metil] sulfinil]-, 2-(((3-Methyl-4-(2 2 2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzimidazole, 2-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole, 2-(2-benzimidazolylsulfinylmethyl)-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine, 2-[[[3-Methyl-4-(2 2 2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole, 2-[[[3-Methyl-4-(2 2 2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole, 2-[[[4-(2 2 2-Trifluoroethoxy)-3-methylpyridin-2-yl]methyl]sulfinyl]-1H-benzimidazole, 2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole,

Complexity	480
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	369.076g/mol
Formal Charge	0
Heavy Atom Count	25
Hydrogen Bond Acceptor Count	8
Hydrogen Bond Donor Count	1
Isotope Atom Count	0
Molecular Weight	369.362g/mol
Monoisotopic Mass	369.076g/mol
Rotatable Bond Count	5
Topological Polar Surface Area	87.1A^2
Undefined Atom Stereocenter Count	1
Undefined Bond Stereocenter Count	0
XLogP3	2.8

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class
Hazard statements	H315-H319-H335
Packing Group
Precautionary statements	P280a-P304+P340-P405-P501a-P305+P351+P338-P261-P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313
UN Code

Certificate of Analysis

Lot Number